Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) HaNDL syndrome: Correlation between focal deficits topography and EEG or SPECT a...
Journal Information
Vol. 31. Issue 5.
Pages 305-310 (June 2016)
Vol. 31. Issue 5.
Pages 305-310 (June 2016)
Original article
DOI: 10.1016/j.nrleng.2015.03.010
Full text access
HaNDL syndrome: Correlation between focal deficits topography and EEG or SPECT abnormalities in a series of 5 new cases
Síndrome HaNDL: correlación entre la topografía del déficit neurológico y las alteraciones en electroencefalograma y SPECT en una serie de 5 nuevos casos
J. Baróna, P. Mulerob, M.I. Pedrazab, C. Gamazoc, C. de la Cruzb, M. Ruizb, M. Ayusoa, M.C. Cebriána, P. García-Talaverac, J. Marcob, A.L. Guerrerob,
Corresponding author

Corresponding author.
a Servicio de Neurofisiología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
b Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
c Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
Article information
Full Text
Download PDF
Tables (4)
Table 1. Clinical and demographic characteristics of the 5 patients.
Table 2. Correlation between neurological deficits and EEG and SPECT findings in our series.
Table 3. Correlation between EEG findings and neurological deficits in the literature.
Table 4. Correlation between SPECT findings and neurological deficits in the literature.
Show moreShow less

Transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL) is characterised by migraine-like headache episodes accompanied by neurological deficits consisting of motor, sensory, or aphasic symptoms. Electroencephalogram (EEG) and single photon emission computed tomography (SPECT) may show focal abnormalities that correspond to the neurological deficits. We aim to evaluate the correlation between focal deficit topography and EEG or SPECT abnormalities in 5 new cases.


We retrospectively reviewed patients attended in a tertiary hospital (January 2010-May 2014) and identified 5 patients (3 men, 2 women) with a mean age of 30.6±7.7 (21-39) years. They presented 3.4±2.6 episodes of headache (range, 2-8) of moderate to severe intensity and transient neurological deficits over a maximum of 5 weeks. Pleocytosis was detected in CSF in all cases (70 to 312cells/mm3, 96.5-100% lymphocytes) with negative results from aetiological studies.


At least one EEG was performed in 4 patients and SPECT in 3 patients. Patient 1: 8 episodes; 4 left hemisphere, 3 right hemisphere, and 1 brainstem; 2 EEGs showing left temporal and bilateral temporal slowing; normal SPECT. Patient 2: 2 episodes, left hemisphere and right hemisphere; SPECT showed decreased left temporal blood flow. Patient 3: 3 left hemisphere deficits; EEG with bilateral frontal and temporal slowing. Patient 4: 2 episodes with right parieto-occipital topography and right frontal slowing in EEG. Patient 5: 2 episodes, right hemisphere and left hemisphere, EEG with right temporal slowing; normal SPECT.


The neurological deficits accompanying headache in HaNDL demonstrate marked clinical heterogeneity. SPECT abnormalities and most of all EEG abnormalities were not uncommon in our series and they did not always correlate to the topography of focal déficits.

LCR pleocytosis
Single photon emission computed tomography

El síndrome de cefalea transitoria y déficits neurológicos con linfocitosis de líquido cefalorraquídeo (LCR), conocido por su acrónimo en inglés, HaNDL, se caracteriza por episodios de cefalea de características migrañosas acompañados por síntomas deficitarios motores, sensitivos o de lenguaje. El electroencefalograma (EEG) o la tomografía por emisión de fotón único (SPECT) pueden mostrar anomalías focales consistentes con los déficits neurológicos. Pretendemos evaluar dicha correlación en una serie de 5 nuevos pacientes.


Análisis retrospectivo de pacientes atendidos en un hospital terciario (enero del 2010-mayo del 2014, 5 casos [3 varones, 2 mujeres]), de 30,6±7,7 años (21-39). Presentaron 3,4±2,6 (2-8) episodios de cefalea moderada-severa y déficits neurológicos durante un tiempo no superior a 5 semanas. En todos, pleocitosis de LCR (70 a 312 células/mm3, 96,5-100% linfocitos), con estudio etiológico negativo.


EEG en 4 pacientes y SPECT en 3. Caso 1: 8 episodios, 4 de hemisferio izquierdo, 3 hemisferio derecho y 1 de tronco, 2 EEG con enlentecimiento temporal izquierdo y bitemporal; SPECT normal. Caso 2: 2 cuadros, hemisférico izquierdo y hemisférico derecho respectivamente y SPECT con flujo disminuido temporal izquierdo. Caso 3: 3 episodios hemisféricos izquierdos; EEG con enlentecimiento temporo-frontal bilateral. Caso 4: 2 cuadros con topografía parieto-occipital derecha y EEG con enlentecimiento frontal derecho. Caso 5: 2 episodios, hemisférico derecho y hemisférico izquierdo, EEG con enlentecimiento temporal derecho; SPECT normal.


Existe gran heterogeneidad clínica en los déficits neurológicos del HaNDL; las alteraciones en SPECT y, sobre todo, en EEG no son infrecuentes y no siempre se relacionan con la topografía clínica.

Palabras clave:
Pleocitosis líquido cefalorraquídeo
Tomografía por emisión de fotón único
Full Text

The syndrome of transient headache and neurological deficits with cerebrospinal fluid (CSF) lymphocytosis (HaNDL) was simultaneously and independently described in 1980 by Swanson et al.,1 who presented 7 cases at the annual meeting of the American Academy of Neurology (which were published a year later),2 and Martí-Massó et al.,3 who presented 3 cases at the extraordinary meeting of the Spanish Society of Neurology, which were subsequently published together with an additional 7 cases in 1984.4–6

HaNDL syndrome is a rare disorder included in the third edition of the International Classification of Headache Disorders (ICHD-3, beta version).7 It is characterised by episodes of migraine-like headache; symptoms of motor, sensory, or language impairment, and lymphocytic pleocytosis, with undetermined aetiology.

Symptoms are benign and self-limiting, and resolve spontaneously in less than 3 months.

Most patients present neurological deficits due to damage to one hemisphere, although several regions may be affected during an episode or successive episodes. Electroencephalography (EEG) and single-photon emission computed tomography (SPECT) have been reported to display focal lesions compatible with neurological deficits.

The purpose of our study is to review the clinical characteristics of HaNDL syndrome and their correlation with EEG and SPECT findings in a series of 5 new patients.

Material and methods

We retrospectively analysed the clinical histories of the patients diagnosed with HaNDL syndrome in a tertiary care hospital between January 2010 and May 2014. In all cases, we recorded demographic and clinical variables, including a history of headache, any potential trigger factors, number of episodes compatible with HaNDL syndrome, and time elapsed between the first and the last episodes. We analysed the characteristics of the headache and the accompanying clinical symptoms of each episode, CSF parameters, and the results of the complementary tests, with an emphasis on EEG and SPECT findings.


We identified a total of 5 patients (3 men and 2 women) with a mean age of 30.6±7.7 years (range, 21-39). Our patients experienced a mean of 3.4±2.62–8 headache episodes of at least moderate intensity and neurological deficits lasting less than 5 weeks in all cases. Two patients had a history of migraine; in these cases, headache episodes compatible with HaNDL syndrome were accompanied by photophobia and/or phonophobia (60%), nausea (20%), or vomiting (20%).

Papilloedema was not observed in any case. In all patients, the CSF analysis revealed pleocytosis (70 to 312cells/mm3), predominantly lymphocytic (96.5%-100%). Table 1 shows the main clinical and CSF characteristics of our 5 patients.

Table 1.

Clinical and demographic characteristics of the 5 patients.

Patient  Sex/age  History of migraine  No. of episodes  CSF
Cells/mm3 (% lymphocytes) 
Proteins (mg/dL) 
Glucose (mg/dL) 
W/24  No  212 (100%)  158  56 
M/34  Yes  95 (98%)  128  62.80 
M/39  No  152 and 312 (100%)  84.6 and 141  73 and 67 
W/21  Yes  70 (98.6%)  58  76 
M/35  No  114 (96.5%)  92.6  69.2 

W: woman; M: man.

The results of the bacterial cultures of CSF were negative in all patients. Autoimmune tests and serological tests for neurotropic viruses, Borrelia, Mycoplasma, Brucella, and human immunodeficiency virus yielded negative results in all 5 cases. Brain magnetic resonance imaging (MRI) studies of all patients showed no abnormalities. A computed tomography (CT) perfusion scan was performed in patients 1 and 3 during one of the episodes. In one case the test showed normal results, whereas in the other it revealed a moderate increase in mean transit time in the whole symptomatic hemisphere, with CT angiography results within normal limits.

At least one EEG study was available for 4 of the patients, and a SPECT study for 3. Patient 1 had undergone 2 EEG studies. The first of these was conducted during the first episodes and showed focal epileptic-like changes. As symptoms persisted (alternating hemiparesis), an additional study was performed, which showed slower, asymmetrical activity in the cortex of both temporal lobes. As was the case in patient 1, patients 3 and 4 showed EEG changes while they were still symptomatic. Symptoms in patient 5 resolved within 24hours and an EEG study performed 5 days later showed a pathological pattern of cortical activity; solely in this case were EEG changes consistent with the location of the neurological deficit. SPECT findings were normal in patients 1 (performed while the patient was symptomatic) and 5 (after symptoms had resolved). In patient 2, SPECT findings were pathological but did not correspond with the symptoms which had started 4 days previously. Table 2 shows the correlation between the neurological deficit symptoms and the complementary test findings.

Table 2.

Correlation between neurological deficits and EEG and SPECT findings in our series.

Patient  Sex/age  No. of episodes  Clinical characteristics of episodes  DSE  EEG  DSS  SPECT 
W/24  4 with right hemiparesis and dysphasia
3 with left hemiparesis
One with paresis in all 4 limbs 
One with left temporal slowing and epileptic-like changes
Predominantly left-sided theta waves in both temporal lobes 
M/34  One with dysphasia and hypoaesthesia in the right upper limb
One with hypoaesthesia and motor impairment in the left upper limb 
–  NP  Decreased blood flow in the left temporal area 
M/39  3 with motor aphasia and right hemiparesis  Bilateral frontotemporal theta waves  –  NP 
W/21  2 with hypoaesthesia in the left limbs with sensory extinction and left homonymous hemianopsia  Right frontal delta waves  –  NP 
M/35  Hemifacial and left upper limb paraesthesia
Right upper limb paraesthesia 
Right temporal theta slowing  12  Normal 

DSE: days elapsed from symptom onset to EEG; DSS: days elapsed from symptom onset to SPECT; W: woman; NP: not performed; M: man.


HaNDL syndrome is a disorder included in the differential diagnosis of stroke since it presents with acute neurological deficits.8,9 In emergency care of these patients, a CT perfusion study may reveal significant reductions in cerebral blood flow and, in the case of HaNDL, possibly cerebral blood volume with a prolongation of mean transit time in an arterial territory,8 as observed in one of our cases.

Most of the references to HaNDL syndrome in the literature are isolated cases or small case series, with the exception of the study by Gómez-Aranda et al. which included 50 patients.10 The most frequent neurological deficits in HaNDL syndrome are sensory disorders (70%), frequently manifesting as paraesthesia or decreased sensitivity of the hand which can later affect the arm and the ipsilateral face but rarely involves the lower limbs. Aphasia is also frequent, presenting in 66% of cases, with pure motor aphasia being the most common type (34%). Motor symptoms have been reported in 42% of patients and manifest as a loss of strength on one side of the body. Visual symptoms are less frequent (18%).10–14 In the majority of patients, focal deficits affect one hemisphere only, although several brain regions may be affected during different episodes11–13 in up to 43% of cases.11

EGG changes and alterations in cerebral blood flow detected by SPECT are traditionally believed to be consistent with focal neurological deficits.12,15 We have found a total of 14 articles describing EEG findings in patients diagnosed with HaNDL syndrome,2,10–12,14–21 and 8 with data from SPECT studies.12,18–20,22 The main findings of these studies are summarised in Tables 3 and 4.

Table 3.

Correlation between EEG findings and neurological deficits in the literature.

Author, year, reference
No. cases 
% EEG changes  EEG findings  Symptom-EEG consistency (%) 
Bartleson et al., 19812
71  Focal slow waves
Generalised slow activity 
Yes (100%) 
Novom et al., 198216
100  Bilateral slow waves
Left temporal theta waves 
Yes (66%) 
Marti-Masso et al., 19834
80  Focal slow activity  NA 
Marti-Masso et al., 19845
100  Slow delta waves  NA 
Walter et al., 198617
100  Delta-theta activity in both frontal lobes  Yes (100%) 
Berg and Williams, 199511
66  Focal slow activity  Yes (100%) 
Caminero et al., 199715
50  Left frontotemporal slow waves  Yes (100%) 
Gómez-Aranda et al., 199710
71  Unilateral focal slowing
Bilateral slowing 
Yes (62%) 
Fuentes et al., 199812
75  Focal slow delta waves
Focal slowing with epileptic-like changes 
Yes (100%) 
Chalaupka Devetag, 200218
100  Focal slowing in the right temporal area  Yes (100%) 
Nomura et al., 200219
100  Reduced amplitude in the right occipital area  Yes (100%) 
Tsukamoto et al., 200320
100  Theta waves in the bilateral frontoparietal region  No 
Tsang et al., 201221
100  Generalised slowing
and bifrontal delta activity 
Filina et al., 201314
100  EEG slowing in the left hemisphere  Yes (100%) 

NA: not available.

Table 4.

Correlation between SPECT findings and neurological deficits in the literature.

Author, year, reference
No. cases 
% SPECT changes  SPECT findings  Symptom-SPECT consistency (%) 
Caminero et al., 199715
75  Decreased focal tracer uptake in the anterior left hemisphere  Yes (100%) 
Gómez-Aranda et al., 199710
100  Hypoperfusion of one hemisphere
Hypoperfusion of both hemispheres 
Yes (33%) 
Arpa and Coya, 199822
100  Increased tracer uptake in the right temporal and parietal lobes  Yes (100%) 
Fuentes et al., 199812
75  Focal reduction in cerebral blood flow  Yes (100%) 
Chalaupka Devetag, 200218
100  Decreased tracer uptake in the left temporal and insula cortices  Yes (100%) 
Nomura et al., 200219
100  Extensive hypoperfusion in the right cerebral hemisphere  Yes (100%) 
Tsukamoto et al., 200320
100  Hypoperfusion in the left fronto-temporo-parietal region  Yes (100%) 
Tada et al., 200513
100  Hypoperfusion in the left frontal and temporal lobes and the left thalamus  Yes (100%) 

EEG changes are present in 86.6% of cases, a percentage comparable with that of our series (100%). The most frequently reported findings consist of focal2,5,10–12,14–16,18 or bilateral10,16,17,20,21 slowing with delta or theta activity, which are again in line with our findings. There is only one previous description of epileptic-like changes similar to those of our patient 1.12 Consistency of EEG changes with neurological deficit topography is far from the traditionally considered 100% (77.3%) but is higher than the 25% found in our series.

SPECT studies show abnormal results in 93.7% of the cases reported in the literature (a percentage above that in our series), and changes are correlated with the topography of the clinical manifestations in 91.6% of the patients. A focal reduction of cerebral blood flow was observed in the vast majority of cases,12,13,15,18,22; furthermore, decreased brain perfusion in a whole hemisphere has also been described.8 We only found one case of focal hyperperfusion in the literature20; this was, however, an atypical case since symptoms recurred after the 3-month time frame defined for HaNDL.

The differential diagnosis between HaNDL and migraine with aura must be established, although CSF changes are specific to this syndrome. Familial hemiplegic migraine is a rare form of migraine with aura that involves motor symptoms: this entity is associated with mutations detected to date in 4 genes (CACNA1A, ATP1A2, SCN1A, and PRRT2).23 Lymphocytosis is characteristic of HaNDL syndrome.11,13 Regarding the complementary test analysed in our study, the SPECT scans performed during migraine auras showed a local reduction of tracer uptake ipsilateral to the origin of the aura symptoms. These abnormalities tend to disappear within 24hours.15 In patients with HaNDL syndrome, in contrast, large hypoperfused brain areas can be found during the acute phase and SPECT tests may display abnormalities for weeks or even months. Regarding EEG findings, 80% of patients with migraine with aura present EEG abnormalities during the ictal phase, corresponding to increased slow-wave baseline cortical EEG activity in 90% of cases; interictal EEG recordings are normal in a higher percentage of cases.24

Lastly, especially during the initial evaluation, HaNDL should be included in the differential diagnosis of stroke, acute meningoencephalitis, and above all meningoencephalitis due to herpes simplex virus 1 (HSV-1). On the one hand, 80% of patients with meningoencephalitis caused by HSV-1 present headaches, 30% to 40% manifest motor deficits, and a third has language disorders.25 EEG abnormalities in these patients can be similar to those described in our series. On the other hand, more than 20% of patients with HaNDL syndrome present fever, and more than half show increased CSF opening pressure.10 In light of the above, the ICHD-3 states that the aetiological study of pleocytosis should be negative.7

In our series, as in previous studies, we observed changes in baseline cortical activity (EEG slowing) and brain hypoperfusion. According to our literature review (Tables 3 and 4), the highest percentages of topographical correlation with clinical deficits correspond to isolated cases or small case series, which possibly overestimate this parameter. The lowest correlations between symptoms and EEG, and symptom and SPECT were observed in a series of 50 patients analysed by Gómez-Aranda et al.10 More than 15 years after that study was published, the aetiology of this entity still remains unknown, as these authors stated. Vascular changes that can be detected during and occasionally weeks after the acute phase, and cortical involvement, as shown by the EEG and maybe related to cortical spreading depression,8 seem diffuse.10 This is why a patient may present different clinical manifestations. Although our study presents some limitations due to its small sample size and retrospective design, the limited correspondence of neurological deficit topography with EEG and SPECT abnormalities in our series support the results obtained by Gómez-Aranda et al. and suggest diffuse involvement in HaNDL syndrome.

Lastly, we recommend performing EEG and SPECT studies in hospitalised patients when there is suspicion of HaNDL syndrome, an infrequent entity whose nature still needs to be understood.


This study has received no funding of any kind.

Conflicts of interest

There are no conflicts of interest to declare.

J.W. Swanson, J.D. Bartleson, J.P. Whisnant.
A migrainous syndrome with CSF pleocytosis abstract.
Neurology, 30 (1980), pp. 418
J.D. Bartleson, J.W. Swanson, J.P. Whisnant.
A migrainous syndrome with cerebrospinal fluid pleocytosis.
Neurology, 31 (1981), pp. 1257-1262
J. Martí-Massó, N. Carrera, W. Astudillo, W. Astudillo, E. De la Puente, J.A. Obeso, et al.
Pseudomigraña con líquido cefalorraquídeo inflamatorio abstract.
Reunión extraordinaria de la Sociedad Española de Neurología. Jaca, 6-7 Junio, (1980),
J.F. Martí-Massó, J. Marti-Massó, J.A. Obeso, N. Carrera, J.M. Martínez-Lage.
Pseudomigraine with CSF lymphocytosis.
Neurology, 33 (1983), pp. 524-525
J. Martí-Massó, J.A. Obeso, N. Carrera, E. De la Puente.
Seudomigraña con líquido cefalorraquídeo inflamatorio: un síndrome benigno.
Med Clin (Barc), 83 (1984), pp. 665-667
S. Martín-Balbuena, F.J. Arpa-Gutierrez.
Pseudomigraña con pleocitosis en el líquido cefalorraquídeo o síndrome de cefalea y déficits neurológicos transitorios con pleocitosis en el líquido cefalorraquídeo. Revisión histórica.
Rev Neurol (Barc), 45 (2007), pp. 624-630
Headache classification committee of the International Headache Society. The international classification of headache disorders 3rd edition (beta, version).
Cephalalgia, 33 (2013), pp. 629-808
J.A. Pettersen, R.I. Aviv, S.E. Black, A.J. Fox, A. Lim, B.J. Murray.
Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke.
T. Krause, C.H. Nolte.
The syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL) as an acute ischemic stoke mimic leading to systemic thrombolysis: a case report.
Clin Neurol Neurosurg, 114 (2012), pp. 689-690
F. Gómez-Aranda, F. Canadillas, J.F. Martí-Massó, E. Díez-Tejedor, P.J. Serrano, R. Leira, et al.
Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases.
Brain, 120 (1997), pp. 1105-1113
M.J. Berg, L.S. Williams.
The transient syndrome of headache with neurologic deficits and CSF lymphocytosis.
Neurology, 45 (1995), pp. 1648-1654
B. Fuentes, E. Diez-Tejedor, J. Pascual, J. Coya, R. Quirce.
Cerebral blood flow changes in pseudomigraine with pleocytosis analyzed by single photon mission computed tomography A spreading depression mechanism?.
Cephalalgia, 18 (1998), pp. 570-573
Y. Tada, K. Negoro, A. Masaaki, J. Ogasawara, M. Kawai, M. Morimatsu.
A patient of migraine-like headache with amnesia, pleocytosis and transient hypoperfusion of cerebral blood flow.
Intern Med, 44 (2005), pp. 743-746
T. Filina, K. Feja, R.W. Tolan Jr.
An adolescent with pseudomigraine transient headache, neurological deficits, and lymphocytic pleocytosis (HaNDL syndrome): case report and review of the literature.
Clin Pediatr (Phila), 52 (2013), pp. 496-502
A.B. Caminero, J.A. Pareja, J. Arpa, F. Vivancos, F. Palomo, J. Coya.
Migrainous syndrome with CSF pleocytosis. SPECT findings.
Headache, 37 (1997), pp. 511-515
M.J. Novom, R. Loren, F. Lhermitte.
Migraine and CSF pleocytosis.
Neurology, 32 (1982), pp. 1073-1075
C.T. Walter, W.A. Grogan.
Migraine with tardy pleocytosis.
Neurology, 36 (1986), pp. 733
F. Chalaupka Devetag.
Headache with temporary neurological symptoms and lymphocytic pleocytosis: a case report and etiologic hypothesis.
Neurol Sci, 23 (2002), pp. 123-125
T. Nomura, Y. Wakutani, K. Doi, Y. Fukada, T. Nakano, H. Kowa, et al.
A case of pseudomigraine with pleocytosis.
Rinsho Shinkeigaku, 42 (2002), pp. 954-958
T. Tsukamoto, K. Miyazawa, K. Narikawa, S. Irino.
A young woman with pseudomigraine with CSF pleocytosis.
Rinsho Shinkeigaku, 43 (2003), pp. 12-15
B.K. Tsang, J.C. Kwong, H.M. Dewey.
Case of syndrome of headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) with focal slowing on electroencephalogram.
Intern Med J, 42 (2012), pp. 944-947
J. Arpa, J. Coya.
Re: Migrainous syndrome with CSF pleocytosis. SPECT findings.
Headache, 38 (1998), pp. 481-482
M.B. Russell, A. Ducros.
Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management.
Lancet Neurol, 10 (2011), pp. 457-470
I. De Carlo, B. Cavaliere, A. Arnaldi, R. Faggioli, S. Soriani, P. Scarpa.
EEG. Evaluation in children and adolescents with chronic headaches.
Eur J Pediatr, 158 (1999), pp. 247-248
R.J. Whitley.
Herpes simplex encephalitis: adolescents and adults.
Antiviral Res, 71 (2006), pp. 141-148

Please cite this article as: Barón J, Mulero P, Pedraza MI, Gamazo C, de la Cruz C, Ruiz M, et al. Síndrome HaNDL: correlación entre la topografía del déficit neurológico y las alteraciones en electroencefalograma y SPECT en una serie de 5 nuevos casos. Neurología. 2016;31:305–310.

Copyright © 2014. Sociedad Española de Neurología
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.